Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.

Gelijkaardige items

• Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
  door: Teng, R, et al.
  Gepubliceerd in: (1996)
• Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
  door: Wise, R, et al.
  Gepubliceerd in: (1996)
• In vitro activity of the new fluoroquinolone CP-99,219.
  door: Neu, H C, et al.
  Gepubliceerd in: (1994)
• In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.
  door: Girard, A E, et al.
  Gepubliceerd in: (1995)
• Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
  door: Hook, E W, et al.
  Gepubliceerd in: (1996)